November 11, 2025 · Form 4 insider transaction
De Witte Jan sold 487 shares of ResMed Inc. at $250.25 per share, a transaction worth $121.9K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
The transaction was conducted under a Rule 10b5-1 plan adopted Feb 03, 2025.